1 Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 1999;18:341-64. [OpenAIRE]
2 Sutton AJ, Abrams KR. Bayesian methods in meta-analysis and evidence synthesis. Stat Methods Med Res 2001;10:277-303.
3 Whitehead A. Meta-analysis of controlled clinical trials. John Wiley & Sons, 2002.
4 Claxton K, Palmer S, Longworth L, et al. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development. Health Technol Assess 2012;16:1-323.
5 Colbourn TE, Asseburg C, Bojke L, et al. Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost efectiveness and value of information analyses. BMJ 2007;335:655. [OpenAIRE]
6 Claxton K, Grifin S, Kofijberg H, et al. Expected health benefits of additional evidence: principles, methods and applications. Research paper 83. Centre for Health Economics, University of York, 2013. [OpenAIRE]
7 Antman EM, Lau J, Kupelnick B, et al. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA 1992;268:240-8. [OpenAIRE]
8 Boland A, Dundar Y, Bagust A, et al. Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation. Health Technol Assess 2003;7:1-136. [OpenAIRE]
9 Lau J, Antman EM, Jimenez-Silva J, et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992;327:248-54. [OpenAIRE]
10 Yusuf S, Collins R, Peto R, et al. Intravenous and intracoronary bifrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-efects from 33 randomized controlled trials. Eur Heart J 1985;6:556-85. [OpenAIRE]
11 Claxton KP, Martin S, Soares MO, et al. Methods for the estimation of the NICE cost efectiveness threshold. Health Technol Assess 2015;19.
12 Fleurence RL, Meltzer DO. Toward a science of research prioritization? The use of value of information by multidisciplinary stakeholder groups. Med Decis Making 2013;33:460-2. [OpenAIRE]
© BMJ Publishing Group Ltd 2015 Web appendix: Numerical example